Delanzomib
CEP-18770 is an orally active inhibitor of the chymotrypsin-like activity of proteasome (IC50: 3.8 nM). It only marginally inhibits the tryptic and peptidylglutamyl activities of the proteosome.
| Catalog Number | T6027 |
| Alternative Name(s) | CEP-18770 |
| Research Area | NF-Κb|||Ubiquitination|||Proteases/Proteasome|||Apoptosis |
| Molecular Formula | C21H28BN3O5 |
| CAS# | 847499-27-8 |
| Purity | 99.46% |
| SMILES | B([C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)c1cccc(n1)c1ccccc1)(O)O |
| Size | 5 mg |
| Supplier Page | https://www.targetmol.com/compound/Delanzomib |
| Additional Information | https://www.targetmol.com/datasheet/T6027 |